Case Study: How RDDC RNA Splicer Accurately Predicts ANK1 Gene Variant Splicing Effects
In genetic disease research, rapidly and accurately assessing the impact of novel genetic variants, especially those at splice sites, is crucial for understanding pathogenic mechanisms. A recent study on Hereditary Spherocytosis (HS) showcased the powerful application value of RDDC RNA Splicer as a cutting-edge AI prediction tool. Researchers utilized this tool to successfully predict the aberrant splicing patterns caused by two de novo variants in the ANK1 gene. The predictions were partially consistent with subsequent complex Minigene experiments, demonstrating RDDC RNA Splicer's reliability as a partner in accelerating splicing mechanism research and guiding experimental design.
Disease Background and Research Challenges
Hereditary Spherocytosis (HS) is a common inherited hemolytic disorder. In this study, the research team focused on two unrelated children clinically diagnosed with HS who carried de novo variants in the ANK1 gene, meaning the variants were not inherited from their parents. High-throughput sequencing identified two previously unreported variants: c.1305+2T>A and c.1305+2del.
Both variants reside at canonical splice donor sites, strongly suggesting they could cause disease by disrupting pre-mRNA splicing. However, precisely which aberrant transcripts would be produced and how the variants interfere with normal splicing were key questions that sequence information alone could not answer.
Precise Predictions by RDDC RNA Splicer
To obtain clear hypotheses before committing wet-lab resources, the team employed the RDDC RNA Splicer tool for in silico analysis of the variants' potential splicing effects. The tool provided specific and detailed predictions:
Detailed Prediction Results
For the c.1305+2del variant, it predicted three possible aberrant splice products:
- 11bp insertion
- 99bp deletion/exon skipping
- 551bp insertion leading to premature termination
For the c.1305+2T>A variant, it similarly predicted three potential aberrant splice forms:
- 12bp insertion
- 99bp deletion/exon skipping
- 552bp insertion leading to premature termination
The RDDC RNA Splicer predictions not only indicated the pathogenic potential but, importantly, delineated specific molecular pathways, providing clear targets for subsequent experimental validation.
Experimental Validation and Result Comparison
To verify the AI tool's predictions, the team conducted Minigene splicing assays. The experimental results were compelling: cells transfected with the mutant plasmids indeed produced aberrant transcripts resulting from the activation of cryptic splice sites, including the predicted ~551/552 bp insertions.
These molecular events observed at the cellular level were partially consistent with the core predictions from RDDC RNA Splicer. This strongly demonstrated that these de novo variants cause Hereditary Spherocytosis by interfering with normal mRNA splicing, leading to impaired synthesis of functional protein.
Clinical Significance and Application Value
This case clearly illustrates that when faced with splice site variants of unknown function, RDDC RNA Splicer can provide rapid, accurate predictions, guide experimental design, and improve research efficiency by helping scientists focus valuable lab resources on the most likely targets.
For researchers on the front lines, RDDC RNA Splicer serves as a powerful engine to effectively link genotype to phenotype and accelerate the process from variant discovery to mechanism elucidation.
Content Source and Disclaimer
This article is a compilation and interpretation of the scientific study cited below, intended to highlight the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publication.
Original Article:
Tian T, Zhang J, Li L, et al. De novo variations of ANK1 gene caused hereditary spherocytosis in two Chinese children by affecting pre-mRNA splicing. BMC Pediatrics. 2022 Dec;22(1):705.
Article Link:
https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-022-03795-0
